Introduction 29 1 35. Holmes S, Hamiter M, Berry C, Mankekar G. Tissue Preservation Techniques for Bone-Anchored Hearing Aid Surgery. Otol Neurotol. 2021 Aug 1;42(7):1044-1050. 36. Limbrick J, Muzaffar J, Kumar R, Mulvihill D, Gaskell P, Addison O, Monksfield P, Banga R. Novel Minimal Access Bone Anchored Hearing Implant Surgery and a New Surface Modified Titanium Implant, the Birmingham Experience. Otol Neurotol. 2019 Dec;40(10):1326-1332 37. Tzortzis S, Tzifa K, Tikka T, Worrollo S, Williams J, Reid AP, Proops D. A ten-year review of soft tissue reactions around percutaneous titanium implants for auricular prosthesis. Laryngoscope. 2015 Aug;125(8):1934-9 38. Dun CA, Faber HT, de Wolf MJ, Mylanus EA, Cremers CW, Hol MK. Assessment of more than 1,000 implanted percutaneous bone conduction devices: skin reactions and implant survival. Otol Neurotol. 2012 Feb;33(2):192-8 39. Holgers KM, Tjellström A, Bjursten LM, Erlandsson BE. Soft tissue reactions around percutaneous implants: a clinical study of soft tissue conditions around skin-penetrating titanium implants for bone-anchored hearing aids. Am J Otol. 1988;9(1):56-59 40. J. Doshi, A.L. McDermott, A. Reid, D. Proops, The 8.5 mm abutment in children: the Birmingham boneanchored hearing aid program experience, Otol. Neurotol. 31 (2010) 612–614 41. Proops DA. The Birmingham bone anchored hearing aid programme: surgical methods and complications. J Laryngol Otol 1996 (suppl): 7-12 42. Shah FA, Thomsen P, Palmquist A. Osseointegration and current interpretations of the bone-implant interface. Acta Biomater. 2019 Jan 15;84:1-15. 43. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. (I). Success criteria and epidemiology. Eur J Oral Sci. 1998 Feb;106(1):527-51. 44. Wilkie MD, Lightbody KA, Salamat AA, Chakravarthy KM, Luff DA, Temple RH. Stability and survival of bone-anchored hearing aid implant systems in post-irradiated patients. Eur Arch Otorhinolaryngol. 2015 Jun;272(6):1371-6. 45. Bezdjian A, Smith RA, Thomeer HGXM, Willie BM, Daniel SJ. A Systematic Review on Factors Associated With Percutaneous Bone Anchored Hearing Implants Loss. Otol Neurotol. 2018 Dec;39(10):e897-e906. 46. Horstink L, Faber HT, de Wolf MJ, Dun CA, Cremers CW, Hol MK. Titanium fixtures for bone-conduction devices and the influence of type 2 diabetes mellitus. Otol Neurotol. 2012; 33(6):1013–7 47. Wazen JJ, Babu S, Daugherty J, Metrailer A. Three-week loading of the 4.5mm wide titanium implant in bone anchored hearing systems. Am J Otolaryngol. 2016 Mar-Apr;37(2):132-5 48. Nelissen RC, den Besten CA, Faber HT, Dun CA, Mylanus EA, Hol MK. Loading of osseointegrated implants for bone conduction hearing at 3 weeks: 3-year stability, survival, and tolerability. Eur Arch Otorhinolaryngol. 2016;273(7):1731-1737 49. McLarnon CM, Johnson I, Davison T, et al. Evidence for early loading of osseointegrated implants for bone conduction at 4 weeks. Otol Neurotol. 2012;33(9):1578-1582. 50. McElveen JT Jr, Green JD Jr, Arriaga MA, Slattery WH 3rd. Next-Day Loading of a Bone-Anchored Hearing System: Preliminary Results. Otolaryngol Head Neck Surg. 2020 Sep;163(3):582-587.
RkJQdWJsaXNoZXIy MTk4NDMw